EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
92 hedge funds and large institutions have $582M invested in Eidos Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $617M → $582M (-$34.2M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
92
Holding in Top 10
3
Calls
$1.66M
Puts
$5K
Top Buyers
| 1 | +$12M | |
| 2 | +$11.3M | |
| 3 | +$4.94M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.77M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$3.77M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$13.3M | |
| 3 | -$11.3M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$6.43M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$4.77M |